The company is finding ways to overcome the headwinds it will encounter in the medium term.
What does Rick Pazdur’s new role mean for the Food and Drug Administration? Has Merck solved the PCSK9 access issue? And how much credit can the president take for lowering GLP-1 drug prices? Dean Li, ...
The rebound is well underway.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback